BRACHYTHERAPY NEEDLES, RP SLEEVE, RP BRACHY-SPACER, GOLD MAKERS
Device Facts
| Record ID | K103449 |
|---|---|
| Device Name | BRACHYTHERAPY NEEDLES, RP SLEEVE, RP BRACHY-SPACER, GOLD MAKERS |
| Applicant | Riverpoint Medical |
| Product Code | KXK · Radiology |
| Decision Date | Feb 25, 2011 |
| Decision | SESE |
| Submission Type | Abbreviated |
| Regulation | 21 CFR 892.5730 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
Brachytherapy Needles: RP Brachytherapy Needles are intended to be used for the placement of radionuclide seeds, and/or gold markers and/or Brachytherapy spacer/sleeve accessories during Brachytherapy or IMRT procedures. Sleeves: The RP Sleeve is intended to be used to facilitate the placement and containment of radioactive seeds and gold markers with or without spacers into the body during Brachytherapy or IMRT procedures. Spacers: The RP Spacer is intended to be used during Brachytherapy or IMRT procedures to facilitate the implant of radionuclide seeds or gold markers at predetermined intervals within the body tissue. Spacers are indicated for use in soft tissues or organ tissue, but not to be used during cardiovascular or neurological procedures. Gold Markers: RP Gold Markers are intended to provide localization information during Brachytherapy, IMRT, or other procedures involving radiation treatments.
Device Story
Riverpoint Medical Brachytherapy system comprises needles, sleeves, spacers, and gold markers used in Brachytherapy or IMRT procedures. Needles deliver radionuclide sources or accessories; sleeves facilitate placement and containment of seeds/markers; spacers maintain predetermined intervals between implants; gold markers (≥99.99% gold) provide radiographic localization. Devices are used by clinicians in clinical settings. System components are provided sterile for single use or non-sterile for processing, sterilized via Ethylene Oxide. Devices do not contain radioactive material; they serve as mechanical delivery and localization aids. Clinical benefit derived from accurate, localized radiation delivery to target tissues.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
Needles, sleeves, spacers, and gold markers. Sleeves composed of extruded polymer. Gold markers ≥99.99% gold. Sterilization via Ethylene Oxide. Mechanical delivery/localization system; no electronic or software components.
Indications for Use
Indicated for patients undergoing Brachytherapy or IMRT procedures requiring placement of radionuclide seeds or gold markers in soft or organ tissues. Contraindicated for use in cardiovascular or neurological procedures.
Regulatory Classification
Identification
A radionuclide brachytherapy source is a device that consists of a radionuclide which may be enclosed in a sealed container made of gold, titanium, stainless steel, or platinum and intended for medical purposes to be placed onto a body surface or into a body cavity or tissue as a source of nuclear radiation for therapy.
Special Controls
*Classification.* Class II (special controls). A prostate seeding kit intended for use with a radionuclide brachytherapy source only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
Predicate Devices
- RP Brachytherapy Needles: CP Medical, K071550
- RP Sleeve: CP Medical, K034062
- RP Spacer: CP Medical, K010621
- Gold Marker: Cortex Manufacturing, K100267
Submission Summary (Full Text)
{0}------------------------------------------------
# 510(k) Summary
K103449
FEB 2 5 2011
### Submitter Information J
Submitter's Name:
Address:
Fax Number:
Contact Person:
825 NE 25th Ave. Portland, OR 97232
Riverpoint Medical
Phone Number: (503) 517-8001 or 866 445-4923
(503) 517-8002
Registration Number:
## 1. Introduction
This document describes the data and methods used to create the 2020 Census Demographic and Housing Characteristics File (DHC) Prototype Product 1. The DHC is a new product that will provide detailed demographic and housing characteristics for small geographic areas. The DHC Prototype Product 1 is a demonstration product that uses data from the 2020 Census, the American Community Survey (ACS), and administrative records to create estimates of demographic and housing characteristics for census blocks. This document provides an overview of the data sources, methods, and evaluation metrics used to create the DHC Prototype Product 1.
The DHC Prototype Product 1 is a valuable tool for understanding the potential of the DHC to provide detailed demographic and housing characteristics for small geographic areas. The DHC Prototype Product 1 can be used to inform the development of the final DHC product.
Douglas Rowley (503) 517-8001
November 12th, 2010
3006981798
Date of Preparation:
510(k) Type
Abbreviated
Device Names
Trade Names:
- 1. Brachytherapy Needles
- 2. RP Sleeve
- 3. RP Spacer
- 4. Gold Marker
Common Names:
Brachytherapy Needle Accessory to Sleeve Spacer Gold Marker
Classification Names:
Brachytherapy Needles, Sleeves, Spacers: System, applicator, radionuclide, manual and Source. Brachytherapy, radionuclide (or accessory to);
Gold Markers: Medical Charged Particle Radiation Therapy System
510(k) Summary - Brachytherapy Needles and Accessories
{1}------------------------------------------------
# Device Classification
FDA Class:
2 (all)
Product Classification:
- 1. Brachy Needles: 892.5730 Radionuclide Brachytherapy Source
- 2. Sleeves: 892.5730 Radionuclide Brachytherapy Source 3. Spacers:
- 892.5730 Radionuclide Brachytherapy Source 4. Gold Markers: 892.5050 Medical Charged Particle Radiation Therapy Sytem
Product Codes:
| 1. Brachy Needles: | KXK |
|--------------------|-----|
| 2. Sleeves: | KXK |
| 3. Spacers: | KXK |
| 4. Gold Markers: | IYE |
# Predicate Devices (applicable 510(k) number listed):
- र मं RP Brachytherapy Needles: CP Medical, K071550 2. RP Sleeve: CP Medical, K034062 3. RP Spacer: CP Medical, K010621 4. Gold Marker: Cortex Manufacturing, K100267
## Special Controls
FDA Guidance "Guidance for the Submission of Premarket Notifications for Photon-Emitting Brachytherapy Sources" was followed (as applicable) during the preparation of this submission due to the product classifications selected for these items.
### Device Descriptions
Riverpoint Medical Brachytherapy Needles and accessories are devices which are used together or independent of each other during Brachytherapy or other IMRT procedures. Intended uses and material information is included below.
Brachytherapy Needles are used to deliver a separately obtained radionuclide source and/or accessory into the patient at the desired location. Intended uses and material information is included below.
RP Sleeves are composed of an extruded polymer material with known biocompatibility which can be used with or without RP Spacers to facilitate the placement of radionuclide seeds into the patient during Brachytherapy or IMRT procedures.
{2}------------------------------------------------
Gold Markers consist of ≥99.99% which can be implanted in order to provide increased visibility at the location of implant. Markers are to be available in a variety of sizes and configurations as desired by customers.
All devices within this submission are provided sterile for one-time use or non-sterile for further processing, and are sterilized via Ethylene Oxide when applicable.
### Intended Uses
### Brachytherapy Needles:
RP Brachytherapy Needles are intended to be used for the placement of radionuclide seeds, and/or gold markers and/or Brachytherapy spacer/sleeve accessories during Brachytherapy or IMRT procedures.
### Sleeves:
The RP Sleeve is intended to be used to facilitate the placement and containment of radioactive seeds and gold markers with or without spacers into the body during Brachytherapy or IMRT procedures.
### Spacers:
The RP Spacer is intended to be used during Brachytherapy or IMRT procedures to facilitate the implant of radionuclide seeds or gold markers at predetermined intervals within the body tissue. Spacers are indicated for use in soft tissues or organ tissue, but not to be used during cardiovascular or neurological procedures.
#### Gold Markers
RP Gold Markers are intended to provide localization information during Brachytherapy, IMRT, or other procedures involving radiation treatments.
### Safety and Effectiveness
Riverpoint Medical Brachytherapy Needles and associated accessories have been designed and manufactured to be substantially equivalent to the predicate devices listed in this submission for all aspects of safety and effectiveness. Although the majority of the product classifications selected for the devices within this submission list radionuclide sources, none of the devices within this submission contain any amount of radioactive material.
#### 510(k) Summary - Brachytherapy Needles and Accessories
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with three overlapping wings, symbolizing health, services, and people. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
## DEPARTMENT OF HEALTH & HUMAN SERVICES
1
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Mr. Doug Rowley RA/QA Manager Riverpoint Medical 825 NE 25th Ave PORTLAND OR 97232
# FEB 25 2011
Re: K103449
Trade/Device Name: Brachytherapy Needle, Brachytherapy Sleeve, Brachytherapy Spacer, and Gold Markers
Regulation Number: 21 CFR 892.5730 Regulation Name: Radionuclide brachytherapy source Regulatory Class: II Product Code: KXK Dated: November 19, 2010 Received: November 23, 2010
Dear Mr. Rowley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
{4}------------------------------------------------
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours.
Mary S Postel
Mary Pastel, ScD. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the words RIVERPOINT MEDICAL in a bold, sans-serif font. The word RIVERPOINT is on the top line, and the word MEDICAL is on the bottom line. The letters are all capitalized and black. The letter O in RIVERPOINT has a triangle inside of it.
510(k) Number:
K.103449
Device Name: Brachytherapy Needle
Unknown at this time
Trade Name: Brachytherapy Needle
Indications for Use:
RP Brachytherapy Needles are intended to be used for the placement of radionuclide seeds, and/or gold markers and/or Brachytherapy spacer/sleeve accessories during Brachytherapy or IMRT procedures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary S. Postell
---
(Division Sign-Off)
Division of Radio Office of In Vi
510K K103449
Page 1 of 1
510(k) Indications for Use Statement - Brachytherapy Needles
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the words "RIVERPOINT MEDICAL" in a bold, sans-serif font. The word "RIVERPOINT" is on the top line, and the word "MEDICAL" is on the second line. The letter "O" in "RIVERPOINT" has a small triangle inside of it.
| 510(k) Number: | Unknown at this time K103449 |
|----------------|------------------------------|
|----------------|------------------------------|
Device Name: Brachytherapy Sleeve
Trade Name: RP Sleeve
Indications for Use:
The RP Sleeve is intended to be used to facilitate the placement and containment of radioactive seeds and gold markers with or without spacers into the body during Brachytherapy or IMRT procedures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary Sastad
(Diving Sign Off)
(Division Sign-Off)
Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety
510K K103449
Page 1 of 1
510(k) Indications for Use Statement ~ Brachytherapy Sleeve
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image contains the words "RIVERPOINT MEDICAL" in a bold, sans-serif font. The word "RIVERPOINT" is on the top line, and "MEDICAL" is on the bottom line. The letters are black against a white background, creating a high-contrast visual.
| 510(k) Number: | Unknown at this time K1034449 |
|----------------|-------------------------------|
|----------------|-------------------------------|
Device Name: Brachytherapy Spacer
Trade Name: RP Spacer
Indications for Use:
The RP Spacer is intended to be used during Brachytherapy or IMRT procedures to facilitate the implant of radionuclide seeds or gold markers at predetermined intervals within the body tissue. Spacers are indicated for use in soft tissues or organ tissue, but not to be used during cardiovascular or neurological procedures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
:
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary Slatel
Office of In Vitro Diagnostic D
510K K103449
Page 1 of 1
510(k) Indications for Use Statement ~ Brachytherapy Spacer
{8}------------------------------------------------
Image /page/8/Picture/0 description: The image shows the words RIVERPOINT MEDICAL in a stacked format. The word RIVERPOINT is on the top line, and the word MEDICAL is on the bottom line. The letters are all in uppercase and in a bold, sans-serif font. The color of the text is black, and the background is white.
510(k) Number: Unknown at this time Device Name: Gold Markers
Gold Markers
Indications for Use:
Trade Name:
RP Gold Markers are intended to provide localization information during Brachytherapy, IMRT, or other procedures involving radiation treatments.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary S Padal
---
(Division Sign-Off)
Office of In Vitro Diagnostic Device Evalu
510K K103449
Page 1 of 1
510(k) Indications for Use Statement - Brachytherapy Needles
